APO Research
Talk to an analyst

APO RESEARCH · REPORT

Albumin

Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.

Selected research

Market Outlook & Growth Opportunities

Global Albumin Market Outlook and Growth Opportunities 2026

20 December 2025196 pages

Choose your research edition.

Industry ResearchAlbumin Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Albumin Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Albumin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Albumin Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Albumin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Albumin is a type of protein synthesized by the liver, which is present in the blood. Bovine serum albumin and human serum albumin are albumins obtained from bovine and human plasma, respectively. Recombinant albumin is manufactured using recombinant techniques in bacteria and viruses.

Global albumin control main manufactuers include CSL, Grifols, Shire (Baxalta), Octapharma, etc., totally accounting for about 42% of the market. Asia Pacific is the largest market, with a share over 65%. As for the types of products, it can be divided into human serum albumin, bovine serum albumin and recombinant albumin. The most common product is human serum albumin, with a share over 93%. In terms of applications, it is widely used in therapeutics, vaccine ingredient, culture medium ingredient and others. The most common application is therapeutics, with a share about 72%.

This report provides an overview of the global Albumin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Albumin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Albumin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Albumin market size, projected growth trends, production technologies, key applications, and end-use industries.

Albumin Segment by Company

CSL

Grifols

Shire (Baxalta)

Octapharma

Hualan Bio

CBPO

RAAS

Kedrion

Merck

LFB Group

Albumedix

Thermo Fisher Scientific

Albumin Segment by Type

Human Serum Albumin

Bovine Serum Albumin

Recombinant Albumin

Albumin Segment by Application

Therapeutics

Vaccine Ingredient

Culture Medium Ingredient

Others

Albumin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Albumin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Albumin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Albumin significant trends, drivers, influence factors in global and regions.

6. To analyze Albumin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albumin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Albumin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albumin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Albumin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Albumin industry.

Chapter 3: Detailed analysis of Albumin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Albumin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Albumin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Albumin Industry Trends Table 2. Albumin Industry Drivers Table 3. Albumin Industry Opportunities and Challenges Table 4. Albumin Industry Restraints Table 5. Global Albumin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Albumin Revenue Share by Company (2021-2026) Table 7. Global Albumin Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Albumin Sales Volume Share by Company (2021-2026) Table 9. Global Albumin Average Price (US$/Kg) of Company (2021-2026) Table 10. Global Albumin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Albumin Key Company Manufacturing Base & Headquarters Table 12. Global Albumin Company, Product Type & Application Table 13. Global Albumin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Albumin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Human Serum Albumin Table 18. Significant Companies of Bovine Serum Albumin Table 19. Significant Companies of Recombinant Albumin Table 20. Global Albumin Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 21. Global Albumin Sales Volume by Type (2021-2026) & (Kg) Table 22. Global Albumin Sales Volume by Type (2027-2032) & (Kg) Table 23. Global Albumin Sales Volume Share by Type (2021-2026) Table 24. Global Albumin Sales Volume Share by Type (2027-2032) Table 25. Global Albumin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Albumin Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Albumin Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Albumin Sales Value Share by Type (2021-2026) Table 29. Global Albumin Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Therapeutics Table 31. Significant Companies of Vaccine Ingredient Table 32. Significant Companies of Culture Medium Ingredient Table 33. Significant Companies of Others Table 34. Global Albumin Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 35. Global Albumin Sales Volume by Application (2021-2026) & (Kg) Table 36. Global Albumin Sales Volume by Application (2027-2032) & (Kg) Table 37. Global Albumin Sales Volume Share by Application (2021-2026) Table 38. Global Albumin Sales Volume Share by Application (2027-2032) Table 39. Global Albumin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Albumin Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Albumin Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Albumin Sales Value Share by Application (2021-2026) Table 43. Global Albumin Sales Value Share by Application (2027-2032) Table 44. Global Albumin Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 45. Global Albumin Sales by Region (2021-2026) & (Kg) Table 46. Global Albumin Sales Market Share by Region (2021-2026) Table 47. Global Albumin Sales by Region (2027-2032) & (Kg) Table 48. Global Albumin Sales Market Share by Region (2027-2032) Table 49. Global Albumin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Albumin Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Albumin Sales Value Share by Region (2021-2026) Table 52. Global Albumin Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Albumin Sales Value Share by Region (2027-2032) Table 54. Global Albumin Market Average Price (US$/Kg) by Region (2021-2026) Table 55. Global Albumin Market Average Price (US$/Kg) by Region (2027-2032) Table 56. Global Albumin Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 57. Global Albumin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Albumin Sales by Country (2021-2026) & (Kg) Table 59. Global Albumin Sales Market Share by Country (2021-2026) Table 60. Global Albumin Sales by Country (2027-2032) & (Kg) Table 61. Global Albumin Sales Market Share by Country (2027-2032) Table 62. Global Albumin Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Albumin Sales Value Market Share by Country (2021-2026) Table 64. Global Albumin Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Albumin Sales Value Market Share by Country (2027-2032) Table 66. CSL Company Information Table 67. CSL Business Overview Table 68. CSL Albumin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 69. CSL Albumin Product Portfolio Table 70. CSL Recent Development Table 71. Grifols Company Information Table 72. Grifols Business Overview Table 73. Grifols Albumin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 74. Grifols Albumin Product Portfolio Table 75. Grifols Recent Development Table 76. Shire (Baxalta) Company Information Table 77. Shire (Baxalta) Business Overview Table 78. Shire (Baxalta) Albumin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 79. Shire (Baxalta) Albumin Product Portfolio Table 80. Shire (Baxalta) Recent Development Table 81. Octapharma Company Information Table 82. Octapharma Business Overview Table 83. Octapharma Albumin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 84. Octapharma Albumin Product Portfolio Table 85. Octapharma Recent Development Table 86. Hualan Bio Company Information Table 87. Hualan Bio Business Overview Table 88. Hualan Bio Albumin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 89. Hualan Bio Albumin Product Portfolio Table 90. Hualan Bio Recent Development Table 91. CBPO Company Information Table 92. CBPO Business Overview Table 93. CBPO Albumin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 94. CBPO Albumin Product Portfolio Table 95. CBPO Recent Development Table 96. RAAS Company Information Table 97. RAAS Business Overview Table 98. RAAS Albumin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 99. RAAS Albumin Product Portfolio Table 100. RAAS Recent Development Table 101. Kedrion Company Information Table 102. Kedrion Business Overview Table 103. Kedrion Albumin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 104. Kedrion Albumin Product Portfolio Table 105. Kedrion Recent Development Table 106. Merck Company Information Table 107. Merck Business Overview Table 108. Merck Albumin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 109. Merck Albumin Product Portfolio Table 110. Merck Recent Development Table 111. LFB Group Company Information Table 112. LFB Group Business Overview Table 113. LFB Group Albumin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 114. LFB Group Albumin Product Portfolio Table 115. LFB Group Recent Development Table 116. Albumedix Company Information Table 117. Albumedix Business Overview Table 118. Albumedix Albumin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 119. Albumedix Albumin Product Portfolio Table 120. Albumedix Recent Development Table 121. Thermo Fisher Scientific Company Information Table 122. Thermo Fisher Scientific Business Overview Table 123. Thermo Fisher Scientific Albumin Sales (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2021-2026) Table 124. Thermo Fisher Scientific Albumin Product Portfolio Table 125. Thermo Fisher Scientific Recent Development Table 126. Key Raw Materials Table 127. Raw Materials Key Suppliers Table 128. Albumin Distributors List Table 129. Albumin Customers List Table 130. Research Programs/Design for This Report Table 131. Authors List of This Report Table 132. Secondary Sources Table 133. Primary Sources List of Figures Figure 1. Albumin Product Image Figure 2. Global Albumin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Albumin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Albumin Sales (2021-2032) & (Kg) Figure 5. Global Albumin Sales Average Price (US$/Kg) & (2021-2032) Figure 6. Global Albumin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Human Serum Albumin Image Figure 10. Bovine Serum Albumin Image Figure 11. Recombinant Albumin Image Figure 12. Global Albumin Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 13. Global Albumin Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Albumin Sales Volume Share by Type (2021-2032) Figure 15. Global Albumin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Albumin Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Albumin Sales Value Share by Type (2021-2032) Figure 18. Therapeutics Image Figure 19. Vaccine Ingredient Image Figure 20. Culture Medium Ingredient Image Figure 21. Others Image Figure 22. Global Albumin Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 23. Global Albumin Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Albumin Sales Volume Share by Application (2021-2032) Figure 25. Global Albumin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Albumin Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Albumin Sales Value Share by Application (2021-2032) Figure 28. Global Albumin Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 29. Global Albumin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Albumin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Albumin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Albumin Sales Value (2021-2032) & (US$ Million) Figure 33. North America Albumin Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Albumin Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Albumin Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Albumin Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Albumin Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Albumin Sales Value (2021-2032) & (US$ Million) Figure 39. South America Albumin Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Albumin Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Albumin Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Albumin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Albumin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Albumin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Albumin Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Albumin Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Human Serum Albumin
  • Bovine Serum Albumin
  • Recombinant Albumin
Applications
  • Therapeutics
  • Vaccine Ingredient
  • Culture Medium Ingredient
  • Others
Companies covered
  • CSL
  • Grifols
  • Shire (Baxalta)
  • Octapharma
  • Hualan Bio
  • CBPO
  • RAAS
  • Kedrion
  • Merck
  • LFB Group
  • Albumedix
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Albumin Sales Value (2021-2032)
  4. 1.2.2 Global Albumin Sales Volume (2021-2032)
  5. 1.2.3 Global Albumin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Albumin Market Dynamics
  1. 2.1 Albumin Industry Trends
  2. 2.2 Albumin Industry Drivers
  3. 2.3 Albumin Industry Opportunities and Challenges
  4. 2.4 Albumin Industry Restraints
3 Albumin Market by Company
  1. 3.1 Global Albumin Company Revenue Ranking in 2025
  2. 3.2 Global Albumin Revenue by Company (2021-2026)
  3. 3.3 Global Albumin Sales Volume by Company (2021-2026)
  4. 3.4 Global Albumin Average Price by Company (2021-2026)
  5. 3.5 Global Albumin Company Ranking (2024-2026)
  6. 3.6 Global Albumin Company Manufacturing Base and Headquarters
  7. 3.7 Global Albumin Company Product Type and Application
  8. 3.8 Global Albumin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Albumin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Albumin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Albumin Market by Type
  1. 4.1 Albumin Type Introduction
  2. 4.1.1 Human Serum Albumin
  3. 4.1.2 Bovine Serum Albumin
  4. 4.1.3 Recombinant Albumin
  5. 4.2 Global Albumin Sales Volume by Type
  6. 4.2.1 Global Albumin Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Albumin Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Albumin Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Albumin Sales Value by Type
  10. 4.3.1 Global Albumin Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Albumin Sales Value by Type (2021-2032)
  12. 4.3.3 Global Albumin Sales Value Share by Type (2021-2032)
5 Albumin Market by Application
  1. 5.1 Albumin Application Introduction
  2. 5.1.1 Therapeutics
  3. 5.1.2 Vaccine Ingredient
  4. 5.1.3 Culture Medium Ingredient
  5. 5.1.4 Others
  6. 5.2 Global Albumin Sales Volume by Application
  7. 5.2.1 Global Albumin Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Albumin Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Albumin Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Albumin Sales Value by Application
  11. 5.3.1 Global Albumin Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Albumin Sales Value by Application (2021-2032)
  13. 5.3.3 Global Albumin Sales Value Share by Application (2021-2032)
6 Albumin Regional Sales and Value Analysis
  1. 6.1 Global Albumin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Albumin Sales by Region (2021-2032)
  3. 6.2.1 Global Albumin Sales by Region: 2021-2026
  4. 6.2.2 Global Albumin Sales by Region (2027-2032)
  5. 6.3 Global Albumin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Albumin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Albumin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Albumin Sales Value by Region (2027-2032)
  9. 6.5 Global Albumin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Albumin Sales Value (2021-2032)
  12. 6.6.2 North America Albumin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Albumin Sales Value (2021-2032)
  15. 6.7.2 Europe Albumin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Albumin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Albumin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Albumin Sales Value (2021-2032)
  21. 6.9.2 South America Albumin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Albumin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Albumin Sales Value Share by Country, 2025 VS 2032
7 Albumin Country-level Sales and Value Analysis
  1. 7.1 Global Albumin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Albumin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Albumin Sales by Country (2021-2032)
  4. 7.3.1 Global Albumin Sales by Country (2021-2026)
  5. 7.3.2 Global Albumin Sales by Country (2027-2032)
  6. 7.4 Global Albumin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Albumin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Albumin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Albumin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Albumin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Albumin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Albumin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Albumin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Albumin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Albumin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Albumin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Albumin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Albumin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Albumin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Albumin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Albumin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Albumin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Albumin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Albumin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Albumin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Albumin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Albumin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Albumin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Albumin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Albumin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Albumin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Albumin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Albumin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Albumin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Albumin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Albumin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Albumin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Albumin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Albumin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Albumin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Albumin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Albumin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Albumin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Albumin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Albumin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Albumin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Albumin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Albumin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Albumin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Albumin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Albumin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Albumin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Albumin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Albumin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Albumin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Albumin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Albumin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Albumin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Albumin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Albumin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Albumin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Albumin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Albumin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Albumin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Albumin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Albumin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Albumin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Albumin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Albumin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Albumin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Albumin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Albumin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Albumin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Albumin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Albumin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Albumin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Albumin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Albumin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Albumin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Albumin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Albumin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Albumin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Albumin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Albumin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Albumin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Albumin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Albumin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Albumin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Albumin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Albumin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Albumin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Albumin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CSL
  2. 8.1.1 CSL Company Information
  3. 8.1.2 CSL Business Overview
  4. 8.1.3 CSL Albumin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 CSL Albumin Product Portfolio
  6. 8.1.5 CSL Recent Developments
  7. 8.2 Grifols
  8. 8.2.1 Grifols Company Information
  9. 8.2.2 Grifols Business Overview
  10. 8.2.3 Grifols Albumin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Grifols Albumin Product Portfolio
  12. 8.2.5 Grifols Recent Developments
  13. 8.3 Shire (Baxalta)
  14. 8.3.1 Shire (Baxalta) Company Information
  15. 8.3.2 Shire (Baxalta) Business Overview
  16. 8.3.3 Shire (Baxalta) Albumin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shire (Baxalta) Albumin Product Portfolio
  18. 8.3.5 Shire (Baxalta) Recent Developments
  19. 8.4 Octapharma
  20. 8.4.1 Octapharma Company Information
  21. 8.4.2 Octapharma Business Overview
  22. 8.4.3 Octapharma Albumin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Octapharma Albumin Product Portfolio
  24. 8.4.5 Octapharma Recent Developments
  25. 8.5 Hualan Bio
  26. 8.5.1 Hualan Bio Company Information
  27. 8.5.2 Hualan Bio Business Overview
  28. 8.5.3 Hualan Bio Albumin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Hualan Bio Albumin Product Portfolio
  30. 8.5.5 Hualan Bio Recent Developments
  31. 8.6 CBPO
  32. 8.6.1 CBPO Company Information
  33. 8.6.2 CBPO Business Overview
  34. 8.6.3 CBPO Albumin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 CBPO Albumin Product Portfolio
  36. 8.6.5 CBPO Recent Developments
  37. 8.7 RAAS
  38. 8.7.1 RAAS Company Information
  39. 8.7.2 RAAS Business Overview
  40. 8.7.3 RAAS Albumin Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 RAAS Albumin Product Portfolio
  42. 8.7.5 RAAS Recent Developments
  43. 8.8 Kedrion
  44. 8.8.1 Kedrion Company Information
  45. 8.8.2 Kedrion Business Overview
  46. 8.8.3 Kedrion Albumin Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Kedrion Albumin Product Portfolio
  48. 8.8.5 Kedrion Recent Developments
  49. 8.9 Merck
  50. 8.9.1 Merck Company Information
  51. 8.9.2 Merck Business Overview
  52. 8.9.3 Merck Albumin Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Merck Albumin Product Portfolio
  54. 8.9.5 Merck Recent Developments
  55. 8.10 LFB Group
  56. 8.10.1 LFB Group Company Information
  57. 8.10.2 LFB Group Business Overview
  58. 8.10.3 LFB Group Albumin Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 LFB Group Albumin Product Portfolio
  60. 8.10.5 LFB Group Recent Developments
  61. 8.11 Albumedix
  62. 8.11.1 Albumedix Company Information
  63. 8.11.2 Albumedix Business Overview
  64. 8.11.3 Albumedix Albumin Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Albumedix Albumin Product Portfolio
  66. 8.11.5 Albumedix Recent Developments
  67. 8.12 Thermo Fisher Scientific
  68. 8.12.1 Thermo Fisher Scientific Company Information
  69. 8.12.2 Thermo Fisher Scientific Business Overview
  70. 8.12.3 Thermo Fisher Scientific Albumin Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Thermo Fisher Scientific Albumin Product Portfolio
  72. 8.12.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Albumin Value Chain Analysis
  2. 9.1.1 Albumin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Albumin Sales Mode & Process
  6. 9.2 Albumin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Albumin Distributors
  9. 9.2.3 Albumin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst